EU Compliance

EU MDR compliance requires manufacturers to address device classification, conformity assessment, technical documentation, clinical evaluation, risk management, quality management, labeling, UDI, and post-market surveillance. Depending on the device class and applicable conformity route, manufacturers may also need assessment by a Notified Body before placing the device on the European market.

CE marking requires the manufacturer to demonstrate conformity with applicable EU MDR requirements. The process generally includes classification, technical documentation, risk management, clinical evaluation, quality-system compliance, and the appropriate conformity assessment. Where required, a Notified Body assesses the applicable requirements before the manufacturer completes the CE marking process.

Yes. Manufacturers established outside the European Union generally need to appoint a European Authorized Representative (EAR) to place applicable medical devices on the EU market. The EAR serves as the manufacturer’s regulatory representative within the EU and supports communication with competent authorities and fulfillment of applicable regulatory obligations.

EU MDR technical documentation must demonstrate that the medical device meets applicable safety and performance requirements. Depending on the device, documentation can include device descriptions, risk management records, clinical evaluation, verification and validation evidence, labeling, instructions for use, and post-market surveillance documentation. The required depth depends on classification and conformity assessment.

EU MDR classification determines the regulatory requirements and conformity assessment pathway applicable to a medical device. Devices are classified according to their risk and intended purpose, with higher-risk devices generally subject to more extensive assessment requirements. Classification can therefore affect technical documentation, clinical evidence, Notified Body involvement, and CE marking.

EU MDR applies to medical devices, while EU IVDR applies specifically to in vitro diagnostic medical devices. Each regulation establishes requirements covering classification, conformity assessment, technical documentation, clinical or performance evidence, labeling, post-market surveillance, and other obligations. Manufacturers must determine which framework applies based on the product’s intended purpose and characteristics.

Manufacturers must establish and maintain a quality management system appropriate to their regulatory obligations under the EU MDR or IVDR. ISO 13485:2016 is a key quality-management standard used within the medical device sector. QMS requirements cover areas such as design and development, production, risk management, supplier controls, and post-market processes.

EUDAMED is the European database supporting transparency and regulatory information exchange for medical devices and economic operators. Compliance activities can include requirements related to device and economic operator information, UDI, and other regulatory data. Manufacturers should assess the applicable EUDAMED obligations as part of their EU market-access strategy.

The EU regulatory framework includes Unique Device Identification (UDI) requirements designed to improve device identification and traceability. Manufacturers need to determine the applicable UDI information and implementation requirements for their devices and integrate them with relevant labeling, packaging, documentation, and regulatory database processes as required under the applicable EU framework.

Transitioning from the legacy Medical Device Directive to EU MDR requires manufacturers to reassess their devices against current MDR requirements. This can involve classification review, technical-documentation updates, clinical evaluation, risk management, QMS changes, labeling and UDI updates, and conformity assessment. Manufacturers should also evaluate applicable transition provisions and their product-specific regulatory status.